Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Histopathology. 2019 Oct 2;75(5):672–682. doi: 10.1111/his.13944

Figure 3. Prognostic significance of PD-L1 and PD-1.

Figure 3.

(Left) The expression of PD-L1 in at least 25% of tumor cells (TC) was associated with worse disease specific survival. (Middle) PD-L1 positivity defined as CPS ≥1 was associated with improved disease specific survival. (Right) The presence of PD-1-positive immune cells (IC) was associated with improved survival.